Radient Technologies - CEO, Harry Kaura
CEO, Harry Kaura
Source: Radient Technologies.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Radient Technologies (RTI) has provided a pair of corporate updates covering financial statements and Health Canada sales licenses
  • The company is temporarily delaying the filing of its 2020 annual financial statements until the end of August
  • This is due to the impending completion of its acquisition of Tunaaaaroom and PBR Labs, as well as an internal review of the business
  • The company also submitted two applications for Health Canada to authorize the sale of dried flower as well as medical cannabis products online
  • Radient Technologies is a commercial manufacturer of cannabis extracts and packaged products
  • Radient Technologies (RTI) is up by 6.67 per cent and is currently trading at $0.08 per share

Radient Technologies (RTI) has provided a pair of corporate updates covering financial statements and Health Canada sales licenses.

2020 annual financials

The company is temporarily delaying its 2020 annual financial statements. This is due to the impending completion of its acquisition of Tunaaaaroom and PBR Labs, as well as an internal review of the business.

The review is evaluating other strategic M&A opportunities to complement the aforementioned acquisitions.

Radient expects to complete the acquisitions by the end of August, at which time it will file its financial statements.

Health Canada applications

The company recently submitted two applications to Health Canada regarding its sales licenses.

The first is for an amendment to its existing sales license to include authorization for online medical cannabis sales directly to registered clients across Canada.

The second is for an additional sales license allowing for the sale of dried flower. 

 Harry Kaura, Radient’s CEO, commented,

“Customer response to our products and brands available in retail cannabis stores has been very positive, and we are very excited at the potential of adding an e-commerce based sales channel to our growing platform. I believe Canadian cannabis consumers will be very pleased with how we intend to launch our online sales channel and continue to deliver positive consumer experiences by providing quality products cannabis connoisseurs love at prices that out-compete their current suppliers.”

Radient Technologies is a commercial manufacturer of cannabis extracts and packaged products.

Radient Technologies (RTI) is up by 6.67 per cent and is currently trading at $0.08 per share as of 11:32 am ET.

More From The Market Herald
Canopy Growth - CEO, David Klein

" Canopy Growth (TSX:WEED) reports Q4 and FY2022 financial results

Canopy Growth Corporation (WEED) has released its financial results for the fourth quarter and fiscal year ended March 31, 2022.

" Revive (CSE:RVV) gets FDA OK for Bucillamine trials to treat COVID-19

Revive Therapeutics (RVV), a cannabis and psychedelic healthcare company has received feedback from the U.S. FDA to help advance Bucillamine.